| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CARDINAL HEALTH INC | 230,800 | 17,933,000 | 13.34% | ||
| 2 | CENCORA | 212,000 | 17,125,000 | 12.74% | ||
| 3 | ANTHEM INC | 135,900 | 17,030,000 | 12.67% | ||
| 4 | INC Research Holdings Inc | 222,875 | 9,936,000 | 7.39% | ||
| 5 | CHARLES RIV LABS INTL INC | 118,612 | 9,885,000 | 7.36% | ||
| 6 | GNC HLDGS INC | 482,955 | 9,862,000 | 7.34% | ||
| 7 | MERCK & CO INC | 157,100 | 9,805,000 | 7.30% | ||
| 8 | ANIKA THERAPEUTICS INC COM | 203,493 | 9,737,000 | 7.25% | ||
| 9 | TRIPLE S MGMT CORP CL B | 429,904 | 9,428,000 | 7.02% | ||
| 10 | TARO PHARMACEUTICAL INDS LTD | 85,205 | 9,416,000 | 7.01% | ||
| 11 | SUPERNUS PHARMACEUTICALS INC COM | 379,533 | 9,386,000 | 6.98% | ||
| 12 | PROGENICS PHARMACEUTICALS IN | 280,000 | 1,772,000 | 1.32% | ||
| 13 | IMMUCELL CORP | 168,323 | 1,301,000 | 0.97% | ||
| 14 | SPDR SERIES TRUST | 20,000 | 915,000 | 0.68% | ||
| 15 | ISHARES TR | 10,000 | 850,000 | 0.63% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-020804, filed 2016.10.24).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
